MAC Stock Recent News
MAC LATEST HEADLINES
Macerich has rallied heavily over the last year as market enthusiasm builds over its Path Forward Plan. The REIT is currently trading for 13.5x times its annualized third-quarter FFO and offers a modest 3.31% dividend yield. The November equity offering should be accretive, but revenue is set to dip in future quarters on asset sales and givebacks.
MAC''s portfolio of premium shopping centers, focus on omnichannel retailing and development of mixed-use assets are strengths despite growing e-commerce adoption.
A2MAC1 Selects Microsoft Azure as its Preferred Cloud Platform and Launches its Cost and Sustainability Suite in the Azure Marketplace.
SANTA MONICA, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- WHAT: Macerich (NYSE: MAC) Schedules Third Quarter 2024 Earnings Release and Conference Call
A portfolio of premium shopping centers, focus on omnichannel retailing and developing mixed-use assets, will likely aid MAC despite growing e-commerce adoption.
Macerich (MAC) reported earnings 30 days ago. What's next for the stock?
MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform today announced topline results from the Phase 2 part of the EBO-301 Phase 2/3 study evaluating epetraborole on top of an optimized background regimen (OBR) in treatment-refractory MAC lung disease. The Phase 2 part of the study met its primary objective of demonstrating the poten.
Macerich's (MAC) Q2 results reflect an increase in same-center net operating income. The company also continues with its portfolio quality refining and balance sheet improving efforts.
MAC reported FFO numbers for its second quarter that dipped 1 cent per share year-over-year. The dividend is 230% covered by FFO but still sits almost 80% below its pre-pandemic level. Management has not made it clear that their path forward plan intends to boost the capacity for more substantial dividend payouts.
Macerich Company delivered solid Q2, 2024 quarter, especially when it comes to the deleveraging front. The asset disposals so far (including those which are under negotiations) explain already 50% of the $2 billion debt recution target. The business performance was relatively solid, where the FFO per share dropped only by $0.01, which could be viewed positively given the multiple pressures.